LYMPHOGENiX Limited

Private

LondonHealthcare & Life Scienceshttps://www.lymphogenix.com/

Last Round

Pre Seed

Jul 8, 2025

Total Funding Raised

$340,000

Company Overview

LYMPHOGENiX Limited is a biotechnology company that develops regenerative medicine products and therapeutics targeting lymphatic regeneration for the treatment of infertility and other fibrotic conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

regenerative medicinelymphatic functionreproductive medicinefertility treatmentcontract research organizationCROIVF supportendometrial healthbiotech reagentspreclinical developmentbioinformaticsfertility techlab servicestranslational researchlivestock biotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LYMPHOGENiX Limited Comparables

Compare LYMPHOGENiX Limited with similar companies based on industry and business-model similarity.

LYMPHOGENiX Limited comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Freya Biosciences	63%
Ferring Pharmaceuticals	60%
Tempest Therapeutics	58%

View all Comparables

LYMPHOGENiX Limited Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Jul 8, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Masashi MATSUNAGA

COO & CBO, Co-Founder

Founding Team

Aarti Gurnani

Chief Executive Officer

Executive Team

LYMPHOGENiX Limited Investors

Notable investors and investment history

LYMPHOGENiX Limited investors
Investor	Rounds
Keio Innovation Initiative	Pre Seed
GLOCALINK Inc.	Pre Seed

View all Investors

LYMPHOGENiX Limited Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

LYMPHOGENiX Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LYMPHOGENiX Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range3

Year Founded2024

Last FundingJul 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.